로딩 중…
지수 로딩 중…
Axsome Therapeutics, Inc.
AXSM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$211.04-3.19%
2026-08-03
Financials
Valuation Metrics
Axsome Therapeutics, Inc.'s Market Cap is $10.86B. At end of 2025 it was $9.25B. Ranked #906 of 3,112 in US market (top 29%), #286 of 1,445 on NASDAQ (top 20%), #42 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 16%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $10.86B | US#906/3,112 Sec#42/269 |
| Revenue | $708M | US#2,163/3,112 Sec#67/269 |
| Net Income | $-188M | US—/3,112 Sec—/269 |
| Total Assets | $714M | US#2,594/3,112 Sec#123/269 |
| Net Assets | $55M | US#2,935/3,112 Sec#241/269 |
| Value | ||
| P/B | 198.95x | US#2,974/3,112 Sec#261/269 |
| P/S | 15.33x | US#2,762/3,112 Sec#140/269 |
| FCF Yield | -0.65% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROA | -26.39% | US#2,839/3,112 Sec#149/269 |
| Op. Margin | -24.80% | US#2,718/3,112 Sec#107/269 |
| Revenue Growth | 57.42% | US#258/3,112 Sec#49/269 |
| Financial Health | ||
| Debt Ratio | 1207.28% | US#2,826/3,112 Sec#249/269 |
| Total Debt | $220M | US#2,152/3,112 Sec#88/269 |
| FCF | $-71M | US#2,523/3,112 Sec#126/269 |
| Cash | $305M | US#1,410/3,112 Sec#79/269 |
| Current Ratio | 1.39x | US#1,781/3,112 Sec#250/269 |
| Performance | ||
| 1Y Return | 104.85% | US#322/3,112 Sec#83/269 |
| 1M Return | -13.62% | US#2,764/3,112 Sec#193/269 |
| From 52W High | -18.89% | US#1,651/3,112 Sec#102/269 |
| 1Y MDD | -18.50% | US#566/3,112 Sec#20/269 |
| Trading | ||
| Volume | 955,184 shares | US#1,522/3,112 Sec#148/269 |
| Trading Value | $202M | US#517/3,112 Sec#26/269 |
| Per Share | ||
| EPS | $-3.62 | US—/3,112 Sec—/269 |
| BPS | $1.74 | US#2,539/3,112 Sec#182/269 |